Innovation and Technology Fund (ITF) _ Local Accelerator Delivery Partner / Acceleration Manager

UK registered organisations can apply for a share of up to £121 million across the three strands of this competition for innovative clean maritime technologies. This funding is from the Department for Transport (DfT).

UK registered organisations can apply for a share of up to £121 million across the three strands of this competition for innovative clean maritime technologies. This funding is from the Department for Transport (DfT).

UK registered organisations can apply for a share of up to £121 million across the three strands of this competition for innovative clean maritime technologies. This funding is from the Department for Transport (DfT).

Funding is available to purchase a die attach/bonding system capable of performing a wide range of bonding processes, including ultrasonic, flip-chip, and UV curing, which is suitable for prototyping and light production runs. As a result, a crucial aspect for any die attach system under is the ability to be used for bonding runs as small as a single die should this be required. This stipulation lends itself to a semi-automated (i.e. motorised) system, ideally with the capacity to store process recipes to maximise reproducibility should the system be used for light production runs.

Funding is available to purchase a laser-based photonic component testing system which is capable of rapidly modifying the wavelength (>100 nm/s sweep rate) with a high level of precision (sub-picometer wavelength resolution). Such a system must also be able to accurately measure the wavelength-dependent power to allow for characterisation of a device under test (DUT). Such a system would strongly complement the photonics capabilities available to the QTIC/BIZ community.

Society’s most important advances have stemmed from those willing to think differently about what might be possible. ARIA is an R&D funding agency built to unlock scientific and technological breakthroughs that benefit everyone. Created by an Act of Parliament, and sponsored by the Department for Science, Innovation, and Technology, ARIA funds breakthrough R&D in under explored areas to catalyse new paths to prosperity for the UK and the world.

The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will broadly focus on closing the treatment gap for individuals with alcohol use disorder (AUD); within this focus, there are five major areas of emphasis: (1) increasing access to treatment for AUD, (2) making treatment for AUD more appealing, (3) examining cost structures and insurance systems, (4) conducting studies on dissemination and implementation of existing evidence-based approaches to treating AUD, and (5) reducing health disparities as a means of addressing the treatment gap in AUD for health disparity populations.

The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Required mechanism focusing on alcohol treatment and recovery research. This NOFO will focus broadly on topics relevant for treatment of and recovery from alcohol use disorder (AUD), including: medications development, precision medicine, behavioral therapies and mechanisms of behavioral change (MOBC), recovery, translational research, and innovative methods and technologies for AUD treatment and recovery.

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications for projects to expand, improve, or transform the utility of mammalian cancer and tumor models for translational research. With this NOFO, the NCI intends to encourage submission of projects devoted to demonstrating that mammalian models or their derivatives used for translational research are robust representations of human biology, are appropriate to test questions of clinical importance, and provide reliable information for patients' benefit. These practical goals contrast with the goals of many mechanistic, NCI-supported R01 projects that employ mammals, or develop and use mammalian cancer models, transplantation tumor models, or models derived from mammalian or human tissues or cells for hypothesis-testing, non-clinical research. Among many other possible endeavors, applicants in response to this FOA could propose demonstrations of how to overcome translational deficiencies of mammalian oncology models, define new uses of mammalian models or their genetics for unexplored translational challenges, advance standard practices for use of translational models, test approaches to validate and credential models, or challenge current practices for how models are used translationally

Romania – Diesel fuel – ACHIZITIE MOTORINA STANDARD